reviewNew England Journal of MedicineMay 19, 2004Closed access

New Drugs for Rheumatoid Arthritis

Vanderbilt University

PubMed
Indexed incrossrefpubmed

Abstract

Rheumatoid arthritis affects about 1 percent of the U.S. population and can cause irreversible joint deformities and functional impairment. Although the cause of this autoimmune disease remains obscure, greater understanding of its underlying mechanisms has facilitated the development of new drugs and revolutionized treatment.

Citation impact

633
total citations
FWCI
45.33
Percentile
100%
References
115
Citations per year

Authors

2

Topics & keywords

Keywords
  • Medicine
  • Rheumatoid arthritis
  • Disease
  • Autoimmune disease
  • Arthritis
  • Functional impairment
  • Intensive care medicine
  • Population
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.